{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:29:00Z","timestamp":1792772940546,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1053\/j.ajkd.2026.08.009","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:14:24Z","timestamp":1792595664000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Initiation of Apixaban Versus Warfarin in Patients With Kidney Failure on Hemodialysis With Newly Diagnosed Atrial Fibrillation: A Target Trial Emulation"],"prefix":"10.1053","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-425X","authenticated-orcid":false,"given":"Wolfgang C.","family":"Winkelmayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Montez-Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin F.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Parker","family":"Gregg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Khairallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara I.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ajkd.2026.08.009_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169400","article-title":"Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI)","volume":"12","author":"Konigsbrugge","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1053\/j.ajkd.2026.08.009_bib2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.kint.2017.11.019","article-title":"Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle","volume":"93","author":"Roy-Chaudhury","year":"2018","journal-title":"Kidney international"},{"issue":"9","key":"10.1053\/j.ajkd.2026.08.009_bib3","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/ndt\/gfx301","article-title":"Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis","volume":"33","author":"Airy","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"21","key":"10.1053\/j.ajkd.2026.08.009_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1053\/j.ajkd.2026.08.009_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"4S","key":"10.1053\/j.ajkd.2026.08.009_bib6","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","journal-title":"Kidney international"},{"key":"10.1053\/j.ajkd.2026.08.009_bib7","unstructured":"U.S. Renal Data System. 2023 Researcher\u2019s Guide to the USRDS Database. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2023."},{"key":"10.1053\/j.ajkd.2026.08.009_bib8","unstructured":"U.S. Renal Data System. 2023 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2023."},{"key":"10.1053\/j.ajkd.2026.08.009_bib9","first-page":"141","article-title":"An empirical transition matrix for nonhomogeneous Markov chains based on censored observations","volume":"5","author":"Aalen","year":"1978","journal-title":"Scand J Stat"},{"issue":"8","key":"10.1053\/j.ajkd.2026.08.009_bib10","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2215\/CJN.11650919","article-title":"Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation","volume":"15","author":"Mavrakanas","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2026.08.009_bib11","article-title":"Effectiveness and Safety of Apixaban Initiation Following Newly-Diagnosed Atrial Fibrillation in Patients With Kidney Failure on Hemodialysis","author":"Winkelmayer","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2026.08.009_bib12","unstructured":"Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project: Elixhauser Comorbidity Software for ICD-10-CM. Available at: https:\/\/hcup-us.ahrq.gov\/toolssoftware\/comorbidityicd10\/comorbidity_icd10.jsp (accession date 10\/25\/2024)."},{"key":"10.1053\/j.ajkd.2026.08.009_bib13","unstructured":"Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project: Clinical Classifications Software Refined (CCSR). Available at: https:\/\/hcup-us.ahrq.gov\/toolssoftware\/ccsr\/ccs_refined.jsp (accession date 10\/25\/2024)."},{"issue":"25","key":"10.1053\/j.ajkd.2026.08.009_bib14","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Statistics in medicine"},{"issue":"27","key":"10.1053\/j.ajkd.2026.08.009_bib15","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1002\/sim.3402","article-title":"Analyses of cumulative incidence functions via non-parametric multiple imputation","volume":"27","author":"Ruan","year":"2008","journal-title":"Statistics in medicine"},{"issue":"3","key":"10.1053\/j.ajkd.2026.08.009_bib16","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10218","article-title":"The Number Needed to Treat: 25 Years of Trials and Tribulations in Clinical Research","volume":"6","author":"Suissa","year":"2015","journal-title":"Rambam Maimonides Med J"},{"key":"10.1053\/j.ajkd.2026.08.009_bib17","unstructured":"Drugs@FDA: FDA Approved Drug Products. Eliquis(R). Labeling-Package Insert. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/202155s000lbl.pdf (accession date: 2\/28\/2019)."},{"issue":"23","key":"10.1053\/j.ajkd.2026.08.009_bib18","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.121.054990","article-title":"Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial","volume":"146","author":"Pokorney","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"10.1053\/j.ajkd.2026.08.009_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.122.062779","article-title":"A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study","volume":"147","author":"Reinecke","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"10.1053\/j.ajkd.2026.08.009_bib20","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1681\/ASN.0000000000000495","article-title":"Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial","volume":"36","author":"Harel","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2026.08.009_bib21","unstructured":"Funding Decisions Database: Strategies for the management of Atrial Fibrillation in patiEnts receiving Dialysis 2 (SAFE-D2). Canadian Institutes of Health Research. Accessed 6\/17\/2026,"},{"issue":"6","key":"10.1053\/j.ajkd.2026.08.009_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1060028017694654","article-title":"Safety Outcomes of Apixaban Compared With Warfarin in Patients With End-Stage Renal Disease","volume":"51","author":"Sarratt","year":"2017","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1053\/j.ajkd.2026.08.009_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/rth2.12083","article-title":"Safety and effectiveness of apixaban compared to warfarin in dialysis patients","volume":"2","author":"Reed","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"10.1053\/j.ajkd.2026.08.009_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/ejh.13599","article-title":"Safety of apixaban compared to warfarin in hemodialysis patients: Do antiplatelets make a difference?","volume":"106","author":"Ionescu","year":"2021","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1053\/j.ajkd.2026.08.009_bib25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/j.ajkd.2022.03.007","article-title":"Apixaban Dosing Patterns Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation Receiving Dialysis: A Retrospective Cohort Study","volume":"80","author":"Wetmore","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"15","key":"10.1053\/j.ajkd.2026.08.009_bib26","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.118.035418","article-title":"Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States","volume":"138","author":"Siontis","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1053\/j.ajkd.2026.08.009_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100926","article-title":"Oral Anticoagulant Initiation in Patients With Kidney Failure on Hemodialysis Newly Diagnosed With Atrial Fibrillation (2007-2020): An Observational Study of Trends and Disparities","volume":"7","author":"Winkelmayer","year":"2025","journal-title":"Kidney Med"},{"issue":"9","key":"10.1053\/j.ajkd.2026.08.009_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1053\/j.ajkd.2026.08.009_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"13","key":"10.1053\/j.ajkd.2026.08.009_bib30","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIR.0b013e31828b82aa","article-title":"Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF\/AHA guideline recommendations): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"Anderson","year":"2013","journal-title":"Circulation"},{"issue":"13","key":"10.1053\/j.ajkd.2026.08.009_bib31","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis","volume":"330","author":"Grams","year":"2023","journal-title":"JAMA"},{"issue":"11","key":"10.1053\/j.ajkd.2026.08.009_bib32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/heartjnl-2016-309266","article-title":"Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease","volume":"103","author":"Yang","year":"2017","journal-title":"Heart"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626011777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626011777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:01:15Z","timestamp":1792764075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638626011777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S0272638626011777"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.08.009","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initiation of Apixaban Versus Warfarin in Patients With Kidney Failure on Hemodialysis With Newly Diagnosed Atrial Fibrillation: A Target Trial Emulation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}